Rigel Pharmaceuticals Inc (RIGL)
Deferred Revenue
$27.97M
Quarterly · Period ending: · USD
RIGL Deferred Revenue
Latest reported$27.97Mperiod ending
Latest reported$27.97Mperiod ending
RIGL Quarterly Deferred Revenue ($2.37M → $27.97M)
Quarterly deferred revenue
High-resolution chart · PNG
RIGL deferred revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Deferred Revenue (USD) |
|---|---|
| 1,257,000 | |
| 2,153,000 | |
| 2,370,000 |